607 related articles for article (PubMed ID: 16258105)
1. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
2. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
3. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
4. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
[TBL] [Abstract][Full Text] [Related]
5. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.
Retsas S; Mastrangelo MJ
Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372
[TBL] [Abstract][Full Text] [Related]
6. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer.
Taylor SH; Merriman KW; Spiess PE; Pisters L
Cancer; 2006 Feb; 106(3):559-65. PubMed ID: 16369982
[TBL] [Abstract][Full Text] [Related]
7. A single-institution validation of the AJCC staging system for stage IV melanoma.
Neuman HB; Patel A; Ishill N; Hanlon C; Brady MS; Halpern AC; Houghton A; Coit DG
Ann Surg Oncol; 2008 Jul; 15(7):2034-41. PubMed ID: 18465172
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
9. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
10. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK; Buettner PG; Leiter U; Garbe C;
J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
[TBL] [Abstract][Full Text] [Related]
11. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy and early-stage melanoma.
Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
[TBL] [Abstract][Full Text] [Related]
13. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database.
Rueth NM; Groth SS; Tuttle TM; Virnig BA; Al-Refaie WB; Habermann EB
Ann Surg Oncol; 2010 Jun; 17(6):1662-8. PubMed ID: 20165985
[TBL] [Abstract][Full Text] [Related]
14. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P
Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
[TBL] [Abstract][Full Text] [Related]
15. Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma.
Hammock L; Cohen C; Carlson G; Murray D; Ross JS; Sheehan C; Nazir TM; Carlson JA
J Cutan Pathol; 2006 Sep; 33(9):599-607. PubMed ID: 16965333
[TBL] [Abstract][Full Text] [Related]
16. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D
J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909
[TBL] [Abstract][Full Text] [Related]
17. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
18. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
19. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract][Full Text] [Related]
20. Demographics and treatment trends in sinonasal mucosal melanoma.
Gal TJ; Silver N; Huang B
Laryngoscope; 2011 Sep; 121(9):2026-33. PubMed ID: 22024859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]